title: Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?
authors.forename: Hendrée E
authors.initials: HE
authors.lastname: Jones
authors.forename: Karol
authors.initials: K
authors.lastname: Kaltenbach
authors.forename: Sarah H
authors.initials: SH
authors.lastname: Heil
authors.forename: Susan M
authors.initials: SM
authors.lastname: Stine
authors.forename: Mara G
authors.initials: MG
authors.lastname: Coyle
authors.forename: Amelia M
authors.initials: AM
authors.lastname: Arria
authors.forename: Kevin E
authors.initials: KE
authors.lastname: O'Grady
authors.forename: Peter
authors.initials: P
authors.lastname: Selby
authors.forename: Peter R
authors.initials: PR
authors.lastname: Martin
authors.forename: Lauren
authors.initials: L
authors.lastname: Jansson
authors.forename: Gabriele
authors.initials: G
authors.lastname: Fischer
mesh_terms: D005260:Female; D005315:Fetal Diseases; D006801:Humans; D011247:Pregnancy; D013375:Substance Withdrawal Syndrome